EP300 (E1A binding protein p300)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
2033 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
E1A binding protein p300 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
EP300 |
SynonymsGene synonyms aliases
|
KAT3B, MKHK2, RSTS2, p300 |
ChromosomeChromosome number
|
22 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
22q13.2 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs28937578 |
C>A,T |
Pathogenic |
Coding sequence variant, missense variant |
rs137853038 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs137853039 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs139310551 |
C>A,T |
Pathogenic |
Coding sequence variant, synonymous variant, stop gained |
rs147583157 |
A>G |
Conflicting-interpretations-of-pathogenicity |
Coding sequence variant, missense variant |
rs150498069 |
C>G,T |
Conflicting-interpretations-of-pathogenicity, benign, likely-benign |
Coding sequence variant, synonymous variant |
rs368437789 |
C>T |
Conflicting-interpretations-of-pathogenicity |
Intron variant |
rs528866215 |
C>T |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs533875300 |
GCA>- |
Pathogenic, likely-benign, benign-likely-benign |
Inframe deletion, coding sequence variant |
rs565779970 |
T>A,C |
Pathogenic, likely-pathogenic |
Synonymous variant, coding sequence variant, stop gained |
rs587778256 |
CCAGTTCCAGCA>- |
Pathogenic, likely-benign |
Coding sequence variant, inframe indel |
rs746398873 |
G>A,T |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, coding sequence variant |
rs786205557 |
C>A |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs797045559 |
->T |
Pathogenic |
Frameshift variant, coding sequence variant |
rs797045560 |
TCAA>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs875989807 |
CAGCAGCAACAG>- |
Likely-pathogenic |
Inframe deletion, coding sequence variant |
rs876661318 |
TATACTCAGAATCCTGGA>- |
Pathogenic |
Inframe deletion, coding sequence variant |
rs879253873 |
->C |
Pathogenic |
Frameshift variant, coding sequence variant |
rs886037664 |
CTCT>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs886041520 |
G>T |
Pathogenic |
Splice acceptor variant |
rs886041739 |
C>G,T |
Pathogenic |
Missense variant, coding sequence variant, stop gained |
rs886041830 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs886042977 |
GTAA>- |
Likely-pathogenic |
Splice donor variant, intron variant |
rs886043598 |
C>A,T |
Pathogenic |
Synonymous variant, coding sequence variant, stop gained |
rs1057517732 |
T>G |
Uncertain-significance, pathogenic, not-provided |
Coding sequence variant, missense variant |
rs1057518002 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057519012 |
->G |
Likely-pathogenic |
Frameshift variant, coding sequence variant |
rs1057519375 |
CA>- |
Pathogenic |
Frameshift variant, coding sequence variant |
rs1057519889 |
G>A,T |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1057521737 |
T>C |
Likely-pathogenic, pathogenic |
Coding sequence variant, missense variant |
rs1064794624 |
->CCTATGTATATCTCCTATACATATCTCCTATCGAACA |
Pathogenic |
Frameshift variant, coding sequence variant |
rs1064795607 |
T>C |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1064797038 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1085307564 |
ACCAACTG>- |
Likely-pathogenic |
Frameshift variant, coding sequence variant |
rs1085307911 |
G>A |
Likely-pathogenic |
Coding sequence variant, missense variant |
rs1114167305 |
G>C |
Pathogenic |
Intron variant |
rs1114167306 |
T>G |
Pathogenic |
Coding sequence variant, missense variant |
rs1210404526 |
C>G,T |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1464734494 |
G>A,C |
Likely-pathogenic |
Synonymous variant, coding sequence variant, missense variant |
rs1555902247 |
TC>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555905780 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555907278 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1555907286 |
C>A |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1555907749 |
->T |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555909666 |
G>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1555909697 |
AAAGA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555910114 |
A>G |
Pathogenic |
Splice acceptor variant |
rs1555910122 |
->G |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555910482 |
AGAA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555910602 |
TTG>- |
Likely-pathogenic |
Inframe deletion, coding sequence variant |
rs1555910814 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1555910821 |
A>G |
Pathogenic-likely-pathogenic |
Missense variant, coding sequence variant |
rs1555911075 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1555911098 |
A>G |
Likely-pathogenic |
Splice acceptor variant |
rs1555911201 |
->AC |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555911313 |
C>G,T |
Pathogenic, not-provided |
Missense variant, coding sequence variant, stop gained |
rs1555911316 |
ACCCAA>- |
Likely-pathogenic |
Inframe indel, coding sequence variant |
rs1555911334 |
G>T |
Likely-pathogenic |
Intron variant |
rs1555911573 |
C>T |
Uncertain-significance, likely-pathogenic |
Missense variant, coding sequence variant |
rs1555911580 |
AGAAAACGAGA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555912040 |
->ATGT |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1555912107 |
T>C,G |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1555912238 |
C>T |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1555912362 |
C>T |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1569090642 |
G>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1569107391 |
->C |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1569108381 |
CACAGAAG>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1569118537 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1569120903 |
A>C |
Pathogenic |
Missense variant, coding sequence variant |
rs1569120910 |
GGA>- |
Pathogenic |
Inframe deletion, coding sequence variant |
rs1569122847 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601598122 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1601598354 |
TGAA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601607265 |
T>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601610306 |
GCCAT>TATGTTGAGCCATAACTGCATGTTGAGCCCA |
Pathogenic |
Inframe indel, coding sequence variant, stop gained |
rs1601613391 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1601617062 |
->A |
Likely-pathogenic |
Intron variant, coding sequence variant, frameshift variant |
rs1601617065 |
A>- |
Pathogenic |
Intron variant, coding sequence variant, frameshift variant |
rs1601618876 |
TATGGGC>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601621480 |
AGAGA>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601621506 |
->T |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601623271 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1601624722 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601624754 |
TG>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601624790 |
->A |
Pathogenic |
Coding sequence variant, stop gained |
rs1601628237 |
->A |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601629319 |
G>A |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1601633128 |
G>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601633708 |
C>T |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1601634247 |
C>T |
Pathogenic |
Coding sequence variant, stop gained |
rs1601636935 |
->T |
Likely-pathogenic |
Coding sequence variant, stop gained |
rs1601639958 |
G>C |
Likely-pathogenic |
Missense variant, coding sequence variant |
rs1601640102 |
GGCCAAC>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601640325 |
C>- |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601640370 |
->C |
Pathogenic |
Coding sequence variant, frameshift variant |
rs1601641819 |
A>- |
Likely-pathogenic |
Coding sequence variant, frameshift variant |
rs1601642812 |
A>G |
Pathogenic |
Stop lost, terminator codon variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IDA |
10733570 |
GO:0000123 |
Component |
Histone acetyltransferase complex |
IBA |
21873635 |
GO:0000977 |
Function |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
IDA |
23811396 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IEA |
|
GO:0001085 |
Function |
RNA polymerase II transcription factor binding |
IBA |
21873635 |
GO:0001102 |
Function |
RNA polymerase II activating transcription factor binding |
IPI |
20018936, 23811396 |
GO:0001666 |
Process |
Response to hypoxia |
IDA |
9887100, 15261140 |
GO:0001756 |
Process |
Somitogenesis |
IEA |
|
GO:0001966 |
Process |
Thigmotaxis |
IEA |
|
GO:0002039 |
Function |
P53 binding |
IEA |
|
GO:0002209 |
Process |
Behavioral defense response |
IEA |
|
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
TAS |
|
GO:0003677 |
Function |
DNA binding |
IDA |
9194565 |
GO:0003682 |
Function |
Chromatin binding |
IDA |
24939902, 25818647 |
GO:0003682 |
Function |
Chromatin binding |
IMP |
17641689 |
GO:0003684 |
Function |
Damaged DNA binding |
IDA |
24939902 |
GO:0003713 |
Function |
Transcription coactivator activity |
IBA |
21873635 |
GO:0003713 |
Function |
Transcription coactivator activity |
IDA |
12435739, 12586840, 12929931, 16687403, 17641689, 18487222 |
GO:0003713 |
Function |
Transcription coactivator activity |
IMP |
11940591 |
GO:0003713 |
Function |
Transcription coactivator activity |
IPI |
23811396 |
GO:0003713 |
Function |
Transcription coactivator activity |
TAS |
10362258 |
GO:0004402 |
Function |
Histone acetyltransferase activity |
IBA |
21873635 |
GO:0004402 |
Function |
Histone acetyltransferase activity |
IDA |
12040021, 14645221, 23415232, 25818647 |
GO:0004402 |
Function |
Histone acetyltransferase activity |
TAS |
10362258 |
GO:0004468 |
Function |
Lysine N-acetyltransferase activity, acting on acetyl phosphate as donor |
IDA |
20019387 |
GO:0005515 |
Function |
Protein binding |
IPI |
1331501, 8684459, 9018065, 9194564, 9194565, 9811832, 9881977, 9887100, 10049825, 10330164, 10518217, 10702269, 10722728, 10866661, 11029584, 11073990, 11430825, 11581164, 11909954, 11940591, 11940655, 12368347, 12435739, 12527917, 12586840, 12743606, 12750254, 12929931, 14645221, 14 |
GO:0005634 |
Component |
Nucleus |
IDA |
9194565, 12929931, 14645221 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005667 |
Component |
Transcription regulator complex |
IBA |
21873635 |
GO:0005694 |
Component |
Chromosome |
IEA |
|
GO:0005829 |
Component |
Cytosol |
IDA |
|
GO:0006110 |
Process |
Regulation of glycolytic process |
IDA |
29775581 |
GO:0006283 |
Process |
Transcription-coupled nucleotide-excision repair |
TAS |
|
GO:0006355 |
Process |
Regulation of transcription, DNA-templated |
IDA |
15261140 |
GO:0006473 |
Process |
Protein acetylation |
IDA |
21030595, 24939902 |
GO:0006473 |
Process |
Protein acetylation |
TAS |
22013210 |
GO:0006475 |
Process |
Internal protein amino acid acetylation |
IDA |
18722353 |
GO:0006915 |
Process |
Apoptotic process |
IMP |
9194565 |
GO:0006977 |
Process |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
TAS |
|
GO:0006990 |
Process |
Positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response |
ISS |
|
GO:0007219 |
Process |
Notch signaling pathway |
TAS |
|
GO:0007221 |
Process |
Positive regulation of transcription of Notch receptor target |
TAS |
|
GO:0007399 |
Process |
Nervous system development |
TAS |
27256286 |
GO:0007507 |
Process |
Heart development |
IEA |
|
GO:0007519 |
Process |
Skeletal muscle tissue development |
IEA |
|
GO:0007611 |
Process |
Learning or memory |
IEA |
|
GO:0007623 |
Process |
Circadian rhythm |
ISS |
|
GO:0008013 |
Function |
Beta-catenin binding |
IPI |
12408825 |
GO:0008022 |
Function |
Protein C-terminus binding |
IDA |
17150957 |
GO:0008134 |
Function |
Transcription factor binding |
IPI |
8684459, 11349124, 15261140, 26504087 |
GO:0008270 |
Function |
Zinc ion binding |
IEA |
|
GO:0009887 |
Process |
Animal organ morphogenesis |
IEA |
|
GO:0010506 |
Process |
Regulation of autophagy |
TAS |
24852146 |
GO:0010742 |
Process |
Macrophage derived foam cell differentiation |
IDA |
26504087 |
GO:0010821 |
Process |
Regulation of mitochondrion organization |
ISS |
|
GO:0010976 |
Process |
Positive regulation of neuron projection development |
IDA |
27256286 |
GO:0016032 |
Process |
Viral process |
IEA |
|
GO:0016407 |
Function |
Acetyltransferase activity |
EXP |
12456660, 16135789, 20228809 |
GO:0016407 |
Function |
Acetyltransferase activity |
IDA |
18722353, 23811396, 24939902 |
GO:0016407 |
Function |
Acetyltransferase activity |
IMP |
12435739 |
GO:0016573 |
Process |
Histone acetylation |
IBA |
21873635 |
GO:0016573 |
Process |
Histone acetylation |
IDA |
25818647, 27256286 |
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0016746 |
Function |
Transferase activity, transferring acyl groups |
IDA |
17403783 |
GO:0018076 |
Process |
N-terminal peptidyl-lysine acetylation |
IDA |
12435739 |
GO:0018215 |
Process |
Protein phosphopantetheinylation |
IEA |
|
GO:0018393 |
Process |
Internal peptidyl-lysine acetylation |
IDA |
17403783 |
GO:0018394 |
Process |
Peptidyl-lysine acetylation |
IDA |
23811396, 23962722 |
GO:0030183 |
Process |
B cell differentiation |
IEA |
|
GO:0030220 |
Process |
Platelet formation |
IEA |
|
GO:0030324 |
Process |
Lung development |
IEA |
|
GO:0030511 |
Process |
Positive regulation of transforming growth factor beta receptor signaling pathway |
IMP |
25514493 |
GO:0031333 |
Process |
Negative regulation of protein-containing complex assembly |
IDA |
23962722 |
GO:0031490 |
Function |
Chromatin DNA binding |
IBA |
21873635 |
GO:0031648 |
Process |
Protein destabilization |
IMP |
24939902 |
GO:0032092 |
Process |
Positive regulation of protein binding |
IEA |
|
GO:0032481 |
Process |
Positive regulation of type I interferon production |
TAS |
|
GO:0032993 |
Component |
Protein-DNA complex |
ISS |
10362258 |
GO:0033613 |
Function |
Activating transcription factor binding |
IPI |
20590529 |
GO:0034644 |
Process |
Cellular response to UV |
IDA |
24939902 |
GO:0035257 |
Function |
Nuclear hormone receptor binding |
IPI |
9862959 |
GO:0035264 |
Process |
Multicellular organism growth |
IEA |
|
GO:0035855 |
Process |
Megakaryocyte development |
IEA |
|
GO:0036268 |
Process |
Swimming |
IEA |
|
GO:0042771 |
Process |
Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
IDA |
17403783 |
GO:0043627 |
Process |
Response to estrogen |
IDA |
11581164 |
GO:0043923 |
Process |
Positive regulation by host of viral transcription |
IDA |
16687403 |
GO:0043967 |
Process |
Histone H4 acetylation |
IMP |
16325578 |
GO:0043969 |
Process |
Histone H2B acetylation |
IDA |
23415232 |
GO:0045444 |
Process |
Fat cell differentiation |
ISS |
|
GO:0045652 |
Process |
Regulation of megakaryocyte differentiation |
TAS |
|
GO:0045721 |
Process |
Negative regulation of gluconeogenesis |
IDA |
30193097 |
GO:0045747 |
Process |
Positive regulation of Notch signaling pathway |
TAS |
|
GO:0045815 |
Process |
Positive regulation of gene expression, epigenetic |
IDA |
25818647 |
GO:0045815 |
Process |
Positive regulation of gene expression, epigenetic |
TAS |
|
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
TAS |
27256286 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
12586840, 18722353, 23811396 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
16325578 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
TAS |
|
GO:0048156 |
Function |
Tau protein binding |
NAS |
28386764 |
GO:0050681 |
Function |
Androgen receptor binding |
IPI |
18487222 |
GO:0050821 |
Process |
Protein stabilization |
ISS |
|
GO:0051059 |
Function |
NF-kappaB binding |
IPI |
23811396 |
GO:0051091 |
Process |
Positive regulation of DNA-binding transcription factor activity |
IDA |
10518217, 25818647 |
GO:0051726 |
Process |
Regulation of cell cycle |
TAS |
|
GO:0060325 |
Process |
Face morphogenesis |
IEA |
|
GO:0060765 |
Process |
Regulation of androgen receptor signaling pathway |
IDA |
18487222 |
GO:0061418 |
Process |
Regulation of transcription from RNA polymerase II promoter in response to hypoxia |
TAS |
|
GO:0061733 |
Function |
Peptide-lysine-N-acetyltransferase activity |
TAS |
|
GO:0061920 |
Function |
Protein propionyltransferase activity |
IDA |
17267393 |
GO:0061921 |
Process |
Peptidyl-lysine propionylation |
IDA |
17267393 |
GO:0090043 |
Process |
Regulation of tubulin deacetylation |
IDA |
18722353 |
GO:0097157 |
Function |
Pre-mRNA intronic binding |
IEA |
|
GO:0097677 |
Function |
STAT family protein binding |
IPI |
26479788 |
GO:0140065 |
Function |
Peptide butyryltransferase activity |
IDA |
17267393, 29775581 |
GO:0140066 |
Process |
Peptidyl-lysine crotonylation |
IDA |
25818647 |
GO:0140067 |
Process |
Peptidyl-lysine butyrylation |
IDA |
17267393, 29775581 |
GO:0140068 |
Function |
Histone crotonyltransferase activity |
IDA |
25818647 |
GO:0140069 |
Function |
Histone butyryltransferase activity |
IEA |
|
GO:1900034 |
Process |
Regulation of cellular response to heat |
TAS |
|
GO:1901224 |
Process |
Positive regulation of NIK/NF-kappaB signaling |
IDA |
23811396 |
GO:1901796 |
Process |
Regulation of signal transduction by p53 class mediator |
TAS |
|
GO:1904837 |
Process |
Beta-catenin-TCF complex assembly |
TAS |
|
GO:1905636 |
Process |
Positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
IDA |
23811396 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q09472 |
Protein name |
Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-) |
Protein function |
Functions as histone acetyltransferase and regulates transcription via chromatin remodeling (PubMed:23415232, PubMed:23934153, PubMed:8945521). Acetylates all four core histones in nucleosomes. Histone acetylation gives an epigenetic tag for transcriptional activation (PubMed:23415232, PubMed:23934153, PubMed:8945521). Mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. Mediates acetylation of histone H3 at 'Lys-122' (H3K122ac), a modification that localizes at the surface of the histone octamer and stimulates transcription, possibly by promoting nucleosome instability. Mediates acetylation of histone H3 at 'Lys-27' (H3K27ac) (PubMed:23911289). Also functions as acetyltransferase for non-histone targets, such as ALX1, HDAC1, PRMT1 or SIRT2 (PubMed:12929931, PubMed:16762839, PubMed:18722353). Acetylates 'Lys-131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates SIRT2 and is proposed to indirectly increase the transcriptional activity of TP53 through acetylation and subsequent attenuation of SIRT2 deacetylase function (PubMed:18722353). Acetylates HDAC1 leading to its inactivation and modulation of transcription (PubMed:16762839). Acetylates 'Lys-247' of EGR2 (By similarity). Acts as a TFAP2A-mediated transcriptional coactivator in presence of CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-dependent transcription of the secretin and p21 genes and controls terminal differentiation of cells in the intestinal epithelium. Promotes cardiac myocyte enlargement. Can also mediate transcriptional repression. Acetylates FOXO1 and enhances its transcriptional activity (PubMed:15890677). Acetylates BCL6 wich disrupts its ability to recruit histone deacetylases and hinders its transcriptional repressor activity (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic gene transcription; exhibits a circadian association with CLOCK or NPAS2, correlating with increase in PER1/2 mRNA and histone H3 acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1 at 'Lys-626' which is essential for its transcriptional coactivator activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation increases protein stability of XBP1 isoform 2 and enhances its transcriptional activity (PubMed:20955178). Acetylates PCNA; acetylation promotes removal of chromatin-bound PCNA and its degradation during nucleotide excision repair (NER) (PubMed:24939902). Acetylates MEF2D (PubMed:21030595). Acetylates and stabilizes ZBTB7B protein by antagonizing ubiquitin conjugation and degragation, this mechanism may be involved in CD4/CD8 lineage differentiation (PubMed:20810990). Acetylates GABPB1, impairing GABPB1 heterotetramerization and activity (By similarity). In addition to protein acetyltransferase, can use different acyl-CoA substrates, such as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA), lactoyl-CoA or propanoyl-CoA (propionyl-CoA), and is able to mediate protein crotonylation, butyrylation, 2-hydroxyisobutyrylation, lactylation or propionylation, respectively (PubMed:17267393, PubMed:25818647, PubMed:29775581, PubMed:31645732). Acts as a histone crotonyltransferase; crotonylation marks active promoters and enhancers and confers resistance to transcriptional repressors (PubMed:25818647). Histone crotonyltransferase activity is dependent on the concentration of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low (PubMed:25818647). Also acts as a histone butyryltransferase; butyrylation marks active promoters (PubMed:17267393). Catalyzes histone lactylation in macrophages by using lactoyl-CoA directly derived from endogenous or exogenous lactate, leading to stimulates gene transcription (PubMed:31645732). Acts as a protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by mediating 2-hydroxyisobutyrylation of glycolytic enzymes (PubMed:29775581). Functions as a transcriptional coactivator for SMAD4 in the TGF-beta signaling pathway (PubMed:25514493). Acetylates PCK1 and promotes PCK1 anaplerotic activity (PubMed:30193097). Acetylates RXRA and RXRG (PubMed:17761950). ; (Microbial infection) In case of HIV-1 infection, it is recruited by the viral protein Tat. Regulates Tat's transactivating activity and may help inducing chromatin remodeling of proviral genes. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein. |
PDB |
1L3E
,
1P4Q
,
2K8F
,
2MH0
,
2MZD
,
3BIY
,
3I3J
,
3IO2
,
3P57
,
3T92
,
4BHW
,
4PZR
,
4PZS
,
4PZT
,
5BT3
,
5KJ2
,
5LKT
,
5LKU
,
5LKX
,
5LKZ
,
5LPK
,
5LPM
,
5NU5
,
5XZC
,
6DS6
,
6FGN
,
6FGS
,
6GYR
,
6GYT
,
6K4N
,
6PF1
,
6PGU
,
6V8B
,
6V8K
,
6V8N
,
6V90
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02135 |
zf-TAZ |
338 → 414 |
TAZ zinc finger |
Family |
PF02172 |
KIX |
566 → 646 |
KIX domain |
Domain |
PF00439 |
Bromodomain |
1058 → 1144 |
Bromodomain |
Domain |
PF06001 |
DUF902 |
1156 → 1195 |
Domain of Unknown Function (DUF902) |
Domain |
PF08214 |
HAT_KAT11 |
1306 → 1612 |
Histone acetylation protein |
Domain |
PF00569 |
ZZ |
1664 → 1705 |
Zinc finger, ZZ type |
Domain |
PF02135 |
zf-TAZ |
1735 → 1806 |
TAZ zinc finger |
Family |
PF09030 |
Creb_binding |
1990 → 2098 |
Creb binding |
Domain |
|
Sequence |
|
Sequence length |
2414 |
Interactions |
View interactions |
|
|